BODE Index vs GOLD Classification in COPD Patients' Anxiety and Depression
Author Information
Author(s): Georg-Christian Funk, Kathrin Kirchheiner, Otto Chris Burghuber, Sylvia Hartl
Primary Institution: Department of Respiratory and Critical Care Medicine and Ludwig Boltzmann Institute for Chronic Obstructive Pulmonary Disease, Otto Wagner Hospital, Vienna, Austria
Hypothesis
Is the BODE index superior to the GOLD classification for explaining anxious and depressive symptoms in COPD patients?
Conclusion
The BODE index is superior to the GOLD classification for explaining anxious and depressive symptoms in COPD patients.
Supporting Evidence
- 49% of patients showed anxious symptoms and 52% showed depressive symptoms.
- Anxiety symptoms increased with BODE stages but not with GOLD stages.
- Depressive symptoms increased with both GOLD and BODE stages.
- The BODE index was superior to FEV1%predicted for explaining anxious and depressive symptoms.
Takeaway
This study found that patients with COPD often feel anxious and depressed, and using a specific scoring system called the BODE index helps understand these feelings better than a traditional method.
Methodology
A cross-sectional study assessing COPD patients using the BODE index and the hospital anxiety and depression scale.
Limitations
The cross-sectional design limits causal inferences, and the small number of patients in GOLD stage I may affect results.
Participant Demographics
68 males and 54 females, average age 65 years.
Statistical Information
P-Value
p<0.001
Confidence Interval
95%CI -21.8 to -9.2
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website